Arcellx (ACLX) Receivables - Accured (2022 - 2025)

Arcellx's quarterly Receivables - Accured came in at $3.6 million in Q4 2025, up 44.0% year-on-year from $2.5 million in Q4 2024, and down 12.2% quarter-over-quarter from $4.1 million in Q3 2025.

Arcellx has reported Receivables - Accured for 4 years, with the latest figure at $3.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Accured rose 44.0% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2025 stood at $3.6 million (up 44.0% YoY), and the FY2025 full-year result was $3.6 million, up 44.0% from the prior year.
  • Receivables - Accured for Q4 2025 stood at $3.6 million, down from $4.1 million in the prior quarter.
  • The five-year high for Receivables - Accured was $4.1 million in Q3 2025, with the low at $500000.0 in Q4 2022.
  • Average Receivables - Accured over 4 years is $2.5 million, with a median of $2.9 million recorded in 2025.
  • Year-over-year, Receivables - Accured surged 210.0% in 2024 and fell 6.45% in 2025.
  • Tracing ACLX's Receivables - Accured over 4 years: stood at $500000.0 in 2022, then soared by 180.0% to $1.4 million in 2023, then surged by 78.57% to $2.5 million in 2024, then soared by 44.0% to $3.6 million in 2025.
  • The last three Receivables - Accured figures came in at $3.6 million (Q4 2025), $4.1 million (Q3 2025), and $3.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acc. Int. Receivables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Arcellx 6.48 Bn 6.48 Bn - 3.60 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.60 Mn
Dec 31, 2025 3.60 Mn
Sep 30, 2025 4.10 Mn
Sep 30, 2025 4.10 Mn
Jun 30, 2025 3.30 Mn
Jun 30, 2025 3.30 Mn
Mar 31, 2025 2.90 Mn
Mar 31, 2025 2.90 Mn
Dec 31, 2024 2.50 Mn
Dec 31, 2024 2.50 Mn
Sep 30, 2024 3.40 Mn
Sep 30, 2024 3.40 Mn
Jun 30, 2024 3.20 Mn
Jun 30, 2024 3.20 Mn
Mar 31, 2024 3.10 Mn
Mar 31, 2024 3.10 Mn
Dec 31, 2023 1.40 Mn
Dec 31, 2023 1.40 Mn
Sep 30, 2023 1.68 Mn
Sep 30, 2023 1.68 Mn
Jun 30, 2023 1.20 Mn
Jun 30, 2023 1.20 Mn
Mar 31, 2023 1.00 Mn
Mar 31, 2023 1.00 Mn
Dec 31, 2022 500,000.00
Dec 31, 2022 500,000.00